BSE Live
Oct 31, 16:01Prev. Close
323.85
Open Price
325.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:47Prev. Close
323.90
Open Price
324.10
Bid Price (Qty.)
325.40 (10)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Gufic Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 745.55 | 769.66 | 679.75 | 713.02 | 433.95 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 745.55 | 769.66 | 679.75 | 713.02 | 433.95 | |
| Total Operating Revenues | 819.81 | 806.67 | 690.62 | 779.16 | 487.70 | |
| Other Income | 3.62 | 2.18 | 2.57 | 3.10 | 3.73 | |
| Total Revenue | 823.42 | 808.84 | 693.19 | 782.26 | 491.43 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 344.20 | 331.26 | 339.36 | 353.93 | 213.45 | |
| Purchase Of Stock-In Trade | 55.41 | 58.06 | 25.84 | 77.42 | 22.55 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -24.91 | 0.57 | -33.39 | -19.39 | 14.29 | |
| Employee Benefit Expenses | 127.19 | 109.63 | 86.73 | 85.61 | 66.22 | |
| Finance Costs | 24.52 | 15.36 | 8.22 | 4.85 | 13.63 | |
| Depreciation And Amortisation Expenses | 21.06 | 17.02 | 22.28 | 17.13 | 16.31 | |
| Other Expenses | 181.52 | 161.27 | 137.42 | 135.87 | 87.27 | |
| Total Expenses | 728.99 | 693.17 | 586.47 | 655.42 | 433.72 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 94.43 | 115.67 | 106.72 | 126.84 | 57.71 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 94.43 | 115.67 | 106.72 | 126.84 | 57.71 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 18.72 | 28.40 | 28.21 | 32.15 | 17.20 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 5.75 | 3.17 | -1.19 | -1.15 | 2.01 | |
| Tax For Earlier Years | 0.02 | -2.03 | 0.00 | 0.00 | -5.73 | |
| Total Tax Expenses | 24.49 | 29.54 | 27.02 | 31.00 | 13.48 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 69.93 | 86.14 | 79.70 | 95.84 | 44.23 | |
| Profit/Loss From Continuing Operations | 69.93 | 86.14 | 79.70 | 95.84 | 44.23 | |
| Profit/Loss For The Period | 69.93 | 86.14 | 79.70 | 95.84 | 44.23 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 6.97 | 8.74 | 8.22 | 9.89 | 4.56 | |
| Diluted EPS (Rs.) | 6.97 | 8.74 | 8.22 | 9.89 | 4.56 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.00 | 0.97 | 0.97 | 0.97 | 0.39 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2024
Gufic Bio Consolidated September 2024 Net Sales at Rs 204.18 crore, down 4.98% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2024
Gufic Bio Consolidated September 2024 Net Sales at Rs 204.18 crore, down 4.98% Y-o-Y